Literature DB >> 26953255

Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.

Lúcio M Barbosa1, Eliana A Reis2, Cláudio R A Dos Santos2, Jackson M Costa2, Theomira M Carmo2, Peace T Aminu3, Thassila N Pitanga2, Rafael Ponce-Terashima4, Walter A Blank3, Luciano K Silva2, Mitermayer G Reis1, Ronald E Blanton5.   

Abstract

Repeated treatments with praziquantel reduce schistosomiasis prevalence and morbidity, but transmission persists and populations often recover within a few years. To identify factors associated with persistence, we surveyed and treated all identified Schistosoma mansoni infections in two rural Brazilian communities (Jenipapo and Volta do Rio) in 2009, 2012 and 2013. Eggs were collected from all infected individuals and genotyped with 11 microsatellite markers to evaluate parasite differentiation and diversity. After successive rounds of community-wide treatment, prevalence decreased from 45% to 24% then 16%. Intensity of infection decreased by 57% over this period, and the number of eggs transmitted to the environment decreased by 92%. During all time periods the majority of eggs were excreted by those >15years of age. The incidence was 23% in 2012 and 15% in 2013, consistent with a decrease in transmission. There was little immigration or gene flow over a distance of 6km. On reinfection, infrapopulations were moderately differentiated indicating that pretreatment multilocus genotypes were not fully reacquired. The effective population size responded to census population decline more rapidly than differentiation. Reinfection was concentrated in the downstream portion of Jenipapo, consistent with the observed increased human fecal contamination. At this scale and in this area S. mansoni infections exist on a fragmented landscape with a highly focal pattern of transmission that may facilitate future elimination.
Copyright © 2016 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brazil; Effective population size; Extinction; Genetic differentiation; Praziquantel; Reinfection; Spatial analysis

Mesh:

Substances:

Year:  2016        PMID: 26953255      PMCID: PMC4844855          DOI: 10.1016/j.ijpara.2016.01.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  34 in total

Review 1.  Drug resistance in human helminths: current situation and lessons from livestock.

Authors:  S Geerts; B Gryseels
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Using Effect Size-or Why the P Value Is Not Enough.

Authors:  Gail M Sullivan; Richard Feinn
Journal:  J Grad Med Educ       Date:  2012-09

3.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 4.  Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.

Authors:  Anthony Danso-Appiah; Sake J De Vlas
Journal:  Trends Parasitol       Date:  2002-03

5.  Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications.

Authors:  D Engels; E Sinzinkayo; B Gryseels
Journal:  Am J Trop Med Hyg       Date:  1996-04       Impact factor: 2.345

6.  Sources and distribution of surface water fecal contamination and prevalence of schistosomiasis in a Brazilian village.

Authors:  Rafael Ponce-Terashima; Amber M Koskey; Mitermayer G Reis; Sandra L McLellan; Ronald E Blanton
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

7.  The relative contribution of immigration or local increase for persistence of urban schistosomiasis in Salvador, Bahia, Brazil.

Authors:  Ronald E Blanton; Lúcio M Barbosa; Eliana A Reis; Theomira M Carmo; Cláudio R A Dos Santos; Jackson M Costa; Peace T Aminu; Walter A Blank; Renato Barbosa Reis; Isabel C Guimarães; Luciano K Silva; Mitermayer G Reis
Journal:  PLoS Negl Trop Dis       Date:  2015-03-16

8.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18

9.  Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.

Authors:  T Huyse; F Van den Broeck; T Jombart; B L Webster; O Diaw; F A M Volckaert; F Balloux; D Rollinson; K Polman
Journal:  Infect Genet Evol       Date:  2013-05-15       Impact factor: 3.342

10.  Characteristics of the human host have little influence on which local Schistosoma mansoni populations are acquired.

Authors:  Lúcio M Barbosa; Luciano K Silva; Eliana A Reis; Theomira M Azevedo; Jackson M Costa; Walter A Blank; Mitermayer G Reis; Ronald E Blanton
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05
View more
  7 in total

Review 1.  Population Structure and Dynamics of Helminthic Infection: Schistosomiasis.

Authors:  Ronald E Blanton
Journal:  Microbiol Spectr       Date:  2019-07

2.  Genetic diversity and structure of Schistosoma japonicum within two marshland villages of Anhui, China, prior to schistosome transmission control and elimination.

Authors:  Huan Ding; Da-Bing Lu; Yu-Meng Gao; Yao Deng; Ying Li
Journal:  Parasitol Res       Date:  2016-11-12       Impact factor: 2.289

3.  The effect of sample size on estimates of genetic differentiation and effective population size for Schistosoma mansoni populations.

Authors:  Lúcio M Barbosa; Bruna C Barros; Moreno de Souza Rodrigues; Luciano K Silva; Mitermayer G Reis; Ronald E Blanton
Journal:  Int J Parasitol       Date:  2018-10-24       Impact factor: 3.981

4.  Schistosoma mansoni schistosomula antigens induce Th1/Pro-inflammatory cytokine responses.

Authors:  Moses Egesa; Lawrence Lubyayi; Edridah M Tukahebwa; Bernard S Bagaya; Iain W Chalmers; Shona Wilson; Cornelis H Hokke; Karl F Hoffmann; David W Dunne; Maria Yazdanbakhsh; Lucja A Labuda; Stephen Cose
Journal:  Parasite Immunol       Date:  2018-10-21       Impact factor: 2.280

Review 5.  Schistosomiasis Morbidity Hotspots: Roles of the Human Host, the Parasite and Their Interface in the Development of Severe Morbidity.

Authors:  Patrice A Mawa; Julien Kincaid-Smith; Edridah M Tukahebwa; Joanne P Webster; Shona Wilson
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

6.  Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.

Authors:  Charlotte M Gower; Florian Gehre; Sara R Marques; Poppy H L Lamberton; Nicholas J Lwambo; Joanne P Webster
Journal:  Parasit Vectors       Date:  2017-12-02       Impact factor: 3.876

7.  Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.

Authors:  Christina L Faust; Marco Crotti; Arinaitwe Moses; David Oguttu; Aidah Wamboko; Moses Adriko; Elizabeth K Adekanle; Narcis Kabatereine; Edridah M Tukahebwa; Alice J Norton; Charlotte M Gower; Joanne P Webster; Poppy H L Lamberton
Journal:  Parasit Vectors       Date:  2019-12-27       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.